Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.05B | 1.95B | 1.82B | 1.86B | 1.81B | 1.86B | Gross Profit |
1.38B | 1.66B | 754.10M | 884.30M | 874.30M | 908.40M | EBIT |
576.90M | 480.20M | 441.40M | 641.50M | 641.00M | 688.00M | EBITDA |
980.20M | 992.70M | 1.18B | 1.19B | 1.16B | 1.06B | Net Income Common Stockholders |
113.20M | 126.90M | 204.90M | -56.80M | 453.40M | 106.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
247.80M | 1.40B | 340.40M | 240.90M | 744.10M | 528.10M | Total Assets |
12.43B | 15.65B | 14.53B | 14.44B | 14.18B | 14.04B | Total Debt |
7.38B | 10.00B | 8.44B | 7.98B | 8.45B | 8.36B | Net Debt |
7.38B | 8.60B | 8.43B | 7.74B | 7.71B | 7.83B | Total Liabilities |
9.60B | 13.60B | 12.02B | 11.48B | 11.15B | 11.08B | Stockholders Equity |
2.82B | 2.06B | 2.51B | 2.96B | 3.03B | 2.96B |
Cash Flow | Free Cash Flow | ||||
8.80M | -19.00M | 93.50M | 305.90M | 221.80M | 135.20M | Operating Cash Flow |
837.50M | 745.10M | 787.50M | 934.40M | 865.80M | 815.20M | Investing Cash Flow |
-1.54B | -731.40M | -593.40M | -639.70M | -555.70M | -598.80M | Financing Cash Flow |
1.40B | 1.04B | -85.00M | -809.70M | -89.70M | -27.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | £7.96B | 6.39 | 32.10% | 2.78% | -24.74% | -63.34% | |
73 Outperform | £51.00B | 16.88 | 8.35% | 4.49% | -7.42% | 5.84% | |
71 Outperform | £7.98B | 34.67 | 12.73% | 4.58% | 5.38% | 86.34% | |
71 Outperform | £19.24B | 16.18 | 12.29% | 3.51% | -13.09% | 231.40% | |
64 Neutral | £7.86B | 29.69 | 13.05% | 4.38% | 8.61% | ― | |
64 Neutral | $8.61B | 10.33 | 4.70% | 4.36% | 4.14% | -13.05% | |
56 Neutral | £2.30B | ― | -4.44% | 7.24% | 20.25% | -128.71% |